Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.

Biochemistry, Genetics and Molecular Biology

• CD34 100%
• Hematopoietic Stem Cell 100%
• Decitabine 75%
• Gene Expression 50%
• Gene Promoter 50%
• CD9 50%
• Gene Expression Profiling 50%
• Quantitative Reverse Transcription Polymerase Chain Reaction 50%
• Methylation 25%
• Bone 25%

Medicine and Dentistry

• Myelodysplastic Syndrome 100%
• Hematopoietic Stem Cell 100%
• Decitabine 75%
• Gene Expression 50%
• In Vitro 50%
• Therapeutic Procedure 50%
• Methylation 25%
• Mononuclear Cell 25%
• Tumor Suppressor Gene 25%
• Cells 25%
• Bone Marrow 25%